Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

BACKGROUND: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe ac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:N Engl J Med
Auteurs principaux: Baden, Lindsey R., El Sahly, Hana M., Essink, Brandon, Kotloff, Karen, Frey, Sharon, Novak, Rick, Diemert, David, Spector, Stephen A., Rouphael, Nadine, Creech, C. Buddy, McGettigan, John, Khetan, Shishir, Segall, Nathan, Solis, Joel, Brosz, Adam, Fierro, Carlos, Schwartz, Howard, Neuzil, Kathleen, Corey, Larry, Gilbert, Peter, Janes, Holly, Follmann, Dean, Marovich, Mary, Mascola, John, Polakowski, Laura, Ledgerwood, Julie, Graham, Barney S., Bennett, Hamilton, Pajon, Rolando, Knightly, Conor, Leav, Brett, Deng, Weiping, Zhou, Honghong, Han, Shu, Ivarsson, Melanie, Miller, Jacqueline, Zaks, Tal
Format: Artigo
Langue:Inglês
Publié: Massachusetts Medical Society 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787219/
https://ncbi.nlm.nih.gov/pubmed/33378609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2035389
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires